Pradžia › Meduloblastoma › Texas
Meduloblastoma klinikiniai tyrimai Texas
8 tyrimai dėl Meduloblastoma ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center, Dallas
- Cook Children's Medical Center, Fort Worth
- Texas Children's Hospital, Houston
Renkami dalyviai2 fazė
59 Months · Visoms lytims · Atnaujinta 2026-09-15 · NCT05535166Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Dell Children's Medical Group SFC-HEM/ONC, Austin
Renkami dalyviai2 fazė
Iki 19 metų · Visoms lytims · Atnaujinta 2026-09-10 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- MD Anderson Cancer Center, Houston
Renkami dalyviai1 fazė
36 Months – 22 Years · Visoms lytims · Atnaujinta 2026-09-04 · NCT03911388Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study
- Baylor College of Medicine, Houston
- MD Anderson Cancer Center, Houston
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 3 iki 50 · Visoms lytims · Atnaujinta 2026-09-01 · NCT07242963Digoxin Medulloblastoma Study
- UT Southwestern, Dallas
Renkami dalyviai2 fazė
12 Months – 30 Years · Visoms lytims · Atnaujinta 2026-08-26 · NCT06701812A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 4 iki 21 · Visoms lytims · Atnaujinta 2026-08-25 · NCT05382338PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Texas Children's Hospital, Houston
Renkami dalyviai2 fazė
Amžius nuo 3 iki 39 · Visoms lytims · Atnaujinta 2026-08-24 · NCT05096481DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- Dell Children's Blood and Cancer Center, Austin
Renkami dalyviai2 fazė
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-12 · NCT04696029Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.